CTCL

Clinical trials for CTCL explained in plain language.

Never miss a new study

Get alerted when new CTCL trials appear

Sign up with your email to follow new studies for CTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New drug cocktail shows promise for rare blood cancers

Disease control Ongoing

This early-phase study tests a combination of three drugs (pembrolizumab, decitabine, and pralatrexate) in adults with relapsed or refractory peripheral T-cell lymphoma or cutaneous T-cell lymphoma. The main goals are to find the safest dose and see if the treatment shrinks tumor…

Matched conditions: CTCL

Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control

Last updated May 11, 2026 20:46 UTC

CTCL

Get alerted when new CTCL trials appear

New drug cocktail shows promise for rare blood cancers